siRNA, Anti-BARD1, 2'-F/2'-OMe/2'-MOE/LNA/Ribo-modified(CAT#: SIRGT01382WQ-2OMe)
The product SIRGT01382WQ-2OMe is a type of small interfering RNA (siRNA) that targets BARD1 gene and regulates the expression of gene. The siRNA interferes with the expression of BARD1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.
| Specifications | |
|---|---|
| NCBI RefSeq | NM_000465.3; NM_001282543.1; NM_001282545.1; NM_001282548.1; NM_001282549.1 |
| Related Diseases | Breast Cancer, Rare Breast Tumor |
| Purification | HPLC |
| Sub Cat | Target | Species | Modification | Scale | |
|---|---|---|---|---|---|
| SIRGT02382WQ-2F | BARD1 | Human | 2ʹ-deoxy-2ʹ-fluoro (2'-F) | ||
| SIRGT03382WQ-2MOE | BARD1 | Human | 2'-O-methoxyethyl (2'-MOE) | ||
| SIRGT04382WQ-LNA | BARD1 | Human | Locked Nucleic Acid (LNA) | ||
| SIRGT01382WQ-RB | BARD1 | Human | Ribo-modified |
